Morphine (Depodur)
Morphine
Pharmaplan (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Pharmaplan (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Depodur 10 EACH 1,0 ml SOLUTION CONTAINS MORPHINE SULPHATE 10,0 mg | 10 | 44011344/2.9/0113 | Cancelled | Not determined | None |
| Depodur 15 EACH 1,5 ml SOLUTION CONTAINS MORPHINE SULPHATE 15,0 mg | 15 | 44108744/2.9/1087 | Cancelled | Not determined | None |
| Depodur 20 EACH 2,0 ml SOLUTION CONTAINS MORPHINE SULPHATE 20,0 mg | 20 | 44108844/2.9/1088 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S6: Morphine
- except preparations and mixtures of morphine containing 0,2 percent or less of morphine, calculated as anhydrous morphine. (S2)
Consolidated Schedules 06 July 2026, lines 10318 to 10319
S2: Morphine
- mixtures containing 0,2 percent or less of morphine, calculated as anhydrous morphine.
Consolidated Schedules 06 July 2026, line 2355
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(4R,4AR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
Drag to rotate. Structure from PubChem CID 5288826.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.